Two Sigma Securities, LLC Esperion Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.96 - $1.79 $35,210 - $65,653	36,678 New	36,678 $35,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $17,216 - $86,081	11,792 New	11,792 $18,000
Q2 2018 Aug 14, 2018	SELL	$36.2 - $76.4 $142,628 - $301,016	-3,940 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $82,490 - $101,030	-1,251 Reduced 24.1%	3,940 $285,000
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $225,652 - $350,029	5,191	5,191 $342,000

215

129M

1.78M

1.27M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $123M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.